Defense Health Program Department of Defense Ovarian Cancer Research Program Funding Opportunities for Fiscal Year 2021 (FY21)

How to Apply: 

The FY21 Defense Appropriations Act is anticipated to provide funding to the Department of Defense OCRP to support patient-centered research to prevent, detect, treat, and cure ovarian cancer to enhance the health and well-being of Service members, Veterans, retirees, their family members, and all women impacted by this disease.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

 

FY21 OCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.    

 

https://cdmrp.army.mil/funding/ocrp

 

Investigator-Initiated Research Award – Pre-application due April 1, 2021

Must be an independent investigator at or above the level of Assistant Professor (or equivalent).

Partnering PI Option:  
Up to two investigators may collaborate on a single application, each of whom will be recognized as a Principal Investigator (PI) and receive a separate award. 

  • Supports meritorious basic and clinically oriented research in ovarian cancer.
  • Impact is an important review criterion.
  • Preliminary data are required.
  • Clinical trials are not allowed. 

Pre-application is required; application submission is by invitation only.

  • Maximum funding of $600,000 for direct costs (plus indirect costs).
  • Maximum funding of $800,000 for direct costs (plus indirect costs) for Partnering PI Option.
  • Maximum period of performance is 4 years.

 

Ovarian Cancer Academy Award – Early-Career Investigator – Pre-application due April 1, 2021

Must be within 5 years of his/her last postdoctoral research position (Ph.D.) or clinical fellowship (M.D.), or equivalent as of the full application submission deadline.

A statement of eligibility is required.

  • Supports the addition of new Early-Career Investigators to the unique, interactive virtual academy providing intensive mentoring, national networking, and a peer group for junior faculty.
  • Early-Career Investigators whose ability to commit to conducting ovarian cancer research is limited by lack of resources or other overwhelming obstacles are encouraged to apply.
  • A Designated Mentor who is an experienced ovarian cancer researcher with ovarian cancer funding is required.
  • A Designated Mentor may only mentor one Early-Career Investigator.
  • The Designated Mentor is not required to be at the same institution as the Early-Career Investigator.
  • Preliminary data are required.
  • Clinical trials are allowed.
  • Pre-application is required; application submission is by invitation only.
  • Maximum funding of $725,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.

 

Pilot Award – Pre-application is Due April 1, 2021

Investigators at or above the postdoctoral level (or equivalent).

  • Supports innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer research forward.
  • Innovation and Impact are important review criteria.
  • Goal is to develop preliminary data; thus, preliminary data are not required, but are allowed.
  • Clinical trials are not allowed.
  • Pre-application is required and blinded; application submission is by invitation only.
  • Maximum funding of $250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.

 

Clinical Translational Research Award - Pre-application Due April 1, 2021

Must be an independent investigator at or above the level of Assistant Professor (or equivalent).

  • Supports translational research addressing high-impact or unmet needs in ovarian cancer.
  • Supports correlative studies related to or associated with planned, ongoing, or completed clinical trials supported by other funding sources. 
  • Emphasis on the utilization of precision medicine and computational approaches that identify individual tumor characteristics and predictive biomarkers across diverse groups to optimize patient care and outcomes.
  • Preliminary data are required.
  • Clinical trials are not allowed.
  • Pre-application is required; application submission is by invitation only.
    • Maximum funding of $450,000 for direct costs (plus indirect costs).
    • Maximum period of performance is 3 years.

 

Proteogenomics Research Award – Pre-application due April 1, 2021

Must be at or above the level of postdoctoral fellow (or equivalent).

  • Supports the genomic and/or transcriptomic and/or proteomic analysis of currently available clinical specimens with a focus on answering biologic and pathophysiologic questions of clinical relevance in ovarian cancer.
  • Innovation and impact are important review criteria.
  • Analysis of clinical trial-derived specimens and/or large patient specimen cohorts is encouraged.
  • Clinical trials are not allowed.
  • Preliminary data are not required but are allowed.
  • Submission of a Letter of Intent is required prior to full application submission.
    • Maximum funding of $250,000 for direct costs (plus indirect costs).
    • Maximum period of performance is 2 years.

 

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

 

For more information about the OCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

 

Point of Contact:

CDMRP Help Desk
301-682-5507 
help@eBrap.org

 

External Deadline: 
Thursday, April 1, 2021
URL: 

https://cdmrp.army.mil/funding/ocrp

Agency: 
Department of Defense
Funding Source: 
External
Funding Level: 
Research